Analyst Research

Report Title Price
Wright Investors Service Comprehensive Report for Genelink, Inc.
Provider: Wright Reports
$460.00
Buy
Genelink Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
GeneLink Inc.
Provider: Datamonitor
$50.00
Buy
Wright Investors Service Core Report for Genelink, Inc.
Provider: Wright Reports
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Genelink Inc Announces Interim CFO Change-Form 8-K


Tuesday, 12 Feb 2013 07:36pm EST 

Genelink Inc reported in its Form 8-K that on January 28, GeneLink, Inc. (Company) accepted the resignation of Susan Hunt as Interim Chief Financial Officer (CFO) of the Company effective as of February 8, 2013. Bernard L. Kasten, Jr., M.D., the CEO and President will assume the duties of interim CFO until such time as the Company hires a replacement CFO. 

Latest Developments for Genelink Inc

Latest Key Developments in Healthcare

Company Quote

Genelink Inc
(GNLK.PK)
0.0124
4.0E-4 +3.33%
18 Jun 2013